Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles

Nature Medicine

Volumn 22, Issue 6, 2016, Pages 685-691

  Cejas, Paloma ^a,b   Li, Lewyn ^a   O'Neill, Nicholas K ^a   Duarte, Melissa ^a   Rao, Prakash ^a   Bowden, Michaela ^a   Zhou, Chensheng W ^a   Mendiola, Marta ^b   Burgos, Emilio ^b   Feliu, Jaime ^b   Moreno Rubio, Juan ^c   Guadalajara, Héctor ^d   Moreno, Víctor ^d   García Olmo, Damián ^d   Bellmunt, Joaquim ^a   Mullane, Stephanie ^a   Hirsch, Michelle ^e   Sweeney, Christopher J ^a   Richardson, Andrea ^e   Liu, X Shirley ^a,f   Brown, Myles ^a   Shivdasani, Ramesh A ^a   Long, Henry W ^a   more..

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^c HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^d Jimenez Diaz Foundation   (Spain)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; FORMALDEHYDE; MESSENGER RNA; PARAFFIN; TRANSCRIPTOME;

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER TISSUE; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL CANCER; CONTROLLED STUDY; ENHANCER REGION; FIXED TISSUE CHROMATIN IMMUNOPRECIPITATION SEQUENCING; FORMALIN FIXED PARAFFIN EMBEDDED TISSUE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; NEXT GENERATION SEQUENCING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEMINOMA; TISSUE FIXATION; ANIMAL; BLADDER TUMOR; CARCINOMA; COLORECTAL TUMOR; DNA SEQUENCE; GENE EXPRESSION PROFILING; GENETIC EPIGENESIS; GENETICS; HIGH THROUGHPUT SEQUENCING; HISTONE CODE; MCF-7 CELL LINE; METABOLISM; MOUSE; NEOPLASM; SEQUENCE ANALYSIS; TRANSITIONAL CELL CARCINOMA; XENOGRAFT;

ANIMALS; CARCINOMA; CARCINOMA, TRANSITIONAL CELL; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL NEOPLASMS; ENHANCER ELEMENTS, GENETIC; EPIGENESIS, GENETIC; FORMALDEHYDE; GENE EXPRESSION PROFILING; HETEROGRAFTS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HISTONE CODE; HUMANS; MCF-7 CELLS; MICE; NEOPLASMS; PARAFFIN EMBEDDING; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, RNA; TISSUE FIXATION; TRANSCRIPTOME; URINARY BLADDER NEOPLASMS;

EID: 84964290493     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4085     Document Type: Article

References (37)

1. Garraway, L.A. & Lander, E.S. Lessons from the cancer genome. Cell 153, 17-37 (2013).
2. Fanelli, M. et al. Pathology tissue-chromatin immunoprecipitation, coupled with high-Throughput sequencing, allows the epigenetic profiling of patient samples. Proc. Natl. Acad. Sci. USA 107, 21535-21540 (2010).
3. Barski, A. et al. High-resolution profiling of histone methylations in the human genome. Cell 129, 823-837 (2007).
4. Shi, S.R., Imam, S.A., Young, L., Cote, R.J. & Taylor, C.R. Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies. J. Histochem. Cytochem. 43, 193-201 (1995).
5. Shi, S.R., Liu, C., Perez, J. & Taylor, C.R. Protein-embedding technique: A potential approach to standardization of immunohistochemistry for formalin-fixed, paraffin-embedded tissue sections. J. Histochem. Cytochem. 53, 1167-1170 (2005).
6. Yamashita, S. Heat-induced antigen retrieval: mechanisms and application to histochemistry. Prog. Histochem. Cytochem. 41, 141-200 (2007).
7. Shin, H., Liu, T., Duan, X., Zhang, Y. & Liu, X.S. Computational methodology for ChIP-seq analysis. Quant. Biol. 1, 54-70 (2013).
8. Anders, S., Pyl, P.T. & Huber, W. HTSeq-A Python framework to work with high-Throughput sequencing data. Bioinformatics 31, 166-169 (2015).
9. Anders, S. & Huber, W. Differential expression analysis for sequence-count data. Genome Biol. 11, R106 (2010).
10. Lee, T.I. et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125, 301-313 (2006).
11. Ben-Porath, I. et al. An embryonic stem-cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40, 499-507 (2008).
12. Hansen, K.D. et al. Increased methylation variation in epigenetic domains across cancer types. Nat. Genet. 43, 768-775 (2011).
13. Balasubramanian, D. et al. H3K4me3 inversely correlates with DNA methylation at a large class of non-CpG-island-containing start sites. Genome Med. 4, 47 (2012).
14. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012).
15. Carroll, J.S. et al. Genome-wide analysis of estrogen-receptor-binding sites. Nat. Genet. 38, 1289-1297 (2006).
16. Ernst, J. & Kellis, M. ChromHMM: Automating chromatin-state discovery and characterization. Nat. Methods 9, 215-216 (2012).
17. Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317-330 (2015).
18. Verzi, M.P. et al. TCF4 and CDX2, major transcription factors for intestinal function, converge on the same cis-regulatory regions. Proc. Natl. Acad. Sci. USA 107, 15157-15162 (2010).
19. Verzi, M.P. et al. Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2. Dev. Cell 19, 713-726 (2010).
20. Hatzis, P. et al. Genome-wide pattern of TCF7L2 (TCF4) chromatin occupancy in colorectal cancer cells. Mol. Cell. Biol. 28, 2732-2744 (2008).
21. van Bragt, M.P., Hu, X., Xie, Y. & Li, Z. RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. eLife 3, e03881 (2014).
22. Santagata, S., Ligon, K.L. & Hornick, J.L. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors. Am. J. Surg. Pathol. 31, 836-845 (2007).
23. Zhang, X., Zhang, J., Wang, T., Esteban, M.A. & Pei, D. Esrrb activates Oct4 transcription and sustains self-renewal and pluripotency in embryonic stem cells. J. Biol. Chem. 283, 35825-35833 (2008).
24. Heng, J.C. et al. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 6, 167-174 (2010).
25. Hnisz, D. et al. Superenhancers in the control of cell identity and disease. Cell 155, 934-947 (2013).
26. Zentner, G.E. & Scacheri, P.C. The chromatin fingerprint of gene enhancer elements. J. Biol. Chem. 287, 30888-30896 (2012).
27. Ong, C.T. & Corces, V.G. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat. Rev. Genet. 12, 283-293 (2011).
28. Kouros-Mehr, H., Slorach, E.M., Sternlicht, M.D. & Werb, Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127, 1041-1055 (2006).
29. Jiang, J. et al. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat. Cell Biol. 10, 353-360 (2008).
30. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315-322 (2014).
31. Robinson, J.T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24-26 (2011).
32. Ramírez, F., Döndar, F., Diehl, S., Gröning, B.A. & Manke, T. deepTools: A flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 42, W187-W191 (2014).
33. Liu, T. et al. Cistrome: An integrative platform for transcriptional regulation studies. Genome Biol. 12, R83 (2011).
34. McLean, C.Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495-501 (2010).
35. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589 (2010).
36. Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550 (2005).
37. Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562-578 (2012).